[Interview Series] Interviews on the NCD Alliance Japan website – Ms. Yukiko Nishimura “Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases” (June 15, 2020)
date : 6/16/2020
The mission of NCD Alliance Japan* is to achieve the creation of a system for NCD policy that is centered on the involvement of people receiving healthcare and other parties most affected by NCDs. To achieve this, it educates and supports leaders from among those most affected by NCDs so they can actively participate in policy creation, such as by serving on national committees and councils.
Please access the links below for the interview:
■ Ms. Yukiko Nishimura NEW
President, Advocacy Service for Rare and Intractable Diseases (NPO ASrid)
“Bringing Multi-Stakeholders Together as Equals in the Field of Rare and Intractable Diseases”
■ Mr. Hiroki Takeda
Chief Knowledge Officer, PPeCC (Power to the People with Chronic Conditions)
Executive Director, Japan Chronic Disease Self-Management Association
“Supporting the Activities of People Living with NCDs to Build an NCD-Friendly Society”
■ Mr.Shinsuke Amano
Chair, The Japan Federation of Cancer Patient Groups
CEO, Group Nexus Japan
“Collaborating across NCDs to achieve “societies in which even people affected by cancer can live with peace of mind””
■ Mr. Takeshi Shukunobe
President and CEO, PPeCC
President and CEO, Patienthood
“Creating a better healthcare environment through a collaborative platform involving people with NCDs and other people most affected”
*NCD Alliance Japan is a collaborative platform for civil society organizations in the NCD community, steered by the Health and Global Policy Institute, aiming to further promote comprehensive, cross-cutting NCD policies.
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
Featured Posts
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-22
[Activity Report] Health Information Project Global Sage Meetings for “Co-creating Health Information Right” (April 22, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-24
[Public Comment Submission] “The Sixth Basic Environment Plan (Draft)” (April 10, 2024)